my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
02-28-2008: Sigma-Aldrich and MorphoSys AG announced a collaboration agreement to design, produce and distribute unique recombinant research antibodies using MorphoSys's proprietary HuCAL GOLD(R) technology. MorphoSys's AbD Serotec unit will develop and qualify unique antibodies from MorphoSys's proprietary HuCAL GOLD library against a committed number of targets identified and supplied by Sigma-Aldrich.
"We are very excited about the potential of this partnership," said Dr. David Smoller, president of Sigma-Aldrich's Research Biotech business unit. "HuCAL-based recombinant antibody technology will allow researchers access to antibody content not available through standard antibody generation technologies. In conjunction with Sigma-Aldrich's standard content generation capabilities, this powerful technology is expected to allow the community to reach its goal of a binder for every gene and one-day even protein in the human body."
Watchlist
This is where you can add this news to your personal favourites
Sigma-Aldrich and MorphoSys AG announced a collaboration agreement to design, produce and distribute unique recombinant research antibodies using MorphoSys's proprietary HuCAL GOLD(R) technology. MorphoSys's AbD Serotec unit will develop and qualify unique antibodies from MorphoSys's propri ... more
MorphoSys Unveils New Antibody Library
MorphoSys AG (Neuer Markt: MOR) today announced the development and release of a new proprietary antibody library, HuCAL® GOLD. The library is to be presented at the 12th IBC Antibody Engineering conference in San Diego, California. Initial results show that the new library and related scre ... more
MorphoSys Expands Target Discovery Capability in Oridis Biomed Collaboration
MorphoSys AG (Neuer Markt: MOR), the German biotechnology company, announced today an Agreement with Oridis Biomed Forschungs- und Entwicklungs GmbH, Graz, Austria, that will provide MorphoSys with preferred access to one of the world’s largest human tissue banks. The goal of the collaborat ... more
Sigma-Aldrich Acquires Vetec Quimica Fina Ltda
Sigma-Aldrich Corporation announced it has acquired all outstanding shares of Vetec Quimica Fina Ltda to strengthen the Company's position in Latin America. Based in Brazil, Vetec is a leading supplier of high quality specialty chemicals for the academic and industrial markets and provides ... more
Sigma-Aldrich Takes Over Global Distribution for BASF Pharma Excipients in Small Pack Sizes
BASF SE and Sigma-Aldrich® have signed a global distribution agreement for a number of BASF’s pharmaceutical excipients. Sigma-Aldrich will repackage the products into small pack sizes making them available for academic-oriented research and development segments like universities and labora ... more
Buhler Group signs inorganic nanoparticles agreement with Sigma-Aldrich
The Buhler Group is making selected dispersions of inorganic nanoparticles accessible worldwide to materials science researchers through an exclusive distribution agreement with Sigma-Aldrich. Buhler and Sigma-Aldrich have signed an agreement in which research volumes of nanoparticle dispe ... more
SIGMA-ALDRICH is a leader in Life Science and High Technology products for research and development more
Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more
Sigma-Aldrich Química, S.A. de C.V.
Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2011 CHEMIE.DE Information Service GmbH, All rights reserved
